Please login to the form below

Not currently logged in
Email:
Password:

GSK to operate lab service for 2012 Games

GlaxoSmithKline (GSK) will provide facilities and equipment to implement anti-doping plans at the 2012 Olympic and Paralympic Games

GlaxoSmithKline (GSK) will provide facilities and equipment to implement anti-doping plans at the 2012 Olympic and Paralympic Games. The London Organising Committee of the Games made the announcement today.

GSK will be the official laboratory services provider in a tier three deal, with GSK providing the facilities to enable King's College London to operate a World Anti-Doping Agency (WADA)  accredited satellite laboratory at the Games.

Thousands of samples will be analysed, with the laboratory in operation 24 hours a day.

Andrew Witty, CEO of GSK said: "The Olympic Games and Paralympic Games provide GSK with a huge opportunity to be part of the delivery of an outstanding world event.

"I'm delighted we've put this alliance with King's College London together to ensure that excellent science can play a key role in ensuring the Games are conducted to the highest ethical standards and that athletes can lead healthier lives. The Olympic and Paralympic ideals of people striving to achieve their best are core to those of GSK, as we share those values of excellence. There is great alignment in these missions and I look forward to our people making a significant contribution to the Olympic Games and Paralympic Games."

30th November 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics